Stéphanie Rouanet

STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry)

G Montalescot, Jean Dallongeville, Éric Van Belle et al. · European Heart Journal · 2006 · 331 citations

B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six‐month, national, multicenter, open‐label study

Jérémie Sellam, Houria Hendel‐Chavez, Stéphanie Rouanet et al. · Arthritis & Rheumatism · 2011 · 154 citations

Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use

Pavel Overtchouk, Paul Guedeney, Stéphanie Rouanet et al. · Journal of the American College of Cardiology · 2018 · 114 citations · Full text

Thrombosis, Cardiovascular Disease, Patient Safety +9

Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis

Jérémie Sellam, Stéphanie Rouanet, Houria Hendel-Chavez et al. · Arthritis & Rheumatism · 2011 · 96 citations · Full text

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab

Adeline Ruyssen‐Witrand, Stéphanie Rouanet, Bernard Combe et al. · Annals of the Rheumatic Diseases · 2012 · 89 citations